Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase theta-4 (GSTT4) is part of the theta class of cytosolic glutathione S-transferases, a family of enzymes involved in phase II detoxification by conjugating glutathione to various electrophilic compounds. However, in humans, GSTT4 is a pseudogene (also called glutathione S-transferase theta pseudogene 1, GSTTP1) and does not encode an active enzyme. Functional GST theta enzymes (such as GSTT1 and GSTT2) do exist in humans and contribute to xenobiotic metabolism and cellular protection against oxidative stress, but GSTT4 retains no catalytic or therapeutic relevance due to its pseudogene status
None for GSTT4 (pseudogene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase theta-4 (GSTT4).